These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29038721)

  • 21. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran.
    Shekarchizadeh H; Ekhtiari H; Khami MR; Virtanen JI
    Harm Reduct J; 2012 Jun; 9():18. PubMed ID: 22676557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of socio-demographic characteristics, substance, and depression among male heroin users attending therapeutic community and methadone maintenance treatment program in Nantou, Taiwan.
    Chen VC; Wu MH; Lin TY; Ho YF; Wang HY; Gossop M
    Subst Abuse Treat Prev Policy; 2015 Oct; 10():41. PubMed ID: 26507876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment.
    Shams I; Sanger N; Bhatt M; Rosic T; Luo C; Shahid H; Mouravska N; Tam SL; Hillmer A; Chawar C; D'Elia A; Hudson J; Marsh D; Thabane L; Samaan Z
    BJPsych Open; 2019 Oct; 5(6):e91. PubMed ID: 31625495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of characteristics and therapy of clients in the extension methadone maintenance therapy clinic].
    Zhang G; Yang Y; Tang R; Hu Y; Xue H; Shan D; Feng Y; Duan S; Sun J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):964-8. PubMed ID: 25582366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcohol Drinking in Chinese Methadone-maintained Clients: A Self-medication for Depression and Anxiety?
    Zhong BL; Xu YM; Xie WX; Lu J; Yu WB; Yan J
    J Addict Med; 2019; 13(4):314-321. PubMed ID: 30633047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual Abuse and its Relation to Chronic Pain among Women from a Methadone Maintenance Clinic versus a Sexual Abuse Treatment Center.
    Peles E; Seligman Z; Bloch M; Potik D; Sason A; Schreiber S; Adelson M
    J Psychoactive Drugs; 2016; 48(4):279-87. PubMed ID: 27430532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Sexual Function and Serum Testosterone Levels in Men Opiate Addicts, under Methadone Maintenance Therapy, and Healthy Men.
    Agha-Mohammadhasani P; Mokhtaree M; Nazari A; Rahnama A
    Addict Health; 2018 Apr; 10(2):76-85. PubMed ID: 31069031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation on the long-term effectiveness among the first set eight methadone maintenance treatment clinics in China].
    Cao XB; Wu ZY; Pang L; Rou KM; Wang CH; Luo W; Yin WY; Mi GD; Li JH;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Sep; 33(9):879-82. PubMed ID: 23290794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey.
    Amin-Esmaeili M; Rahimi-Movaghar A; Sharifi V; Hajebi A; Radgoodarzi R; Mojtabai R; Hefazi M; Motevalian A
    Addiction; 2016 Oct; 111(10):1836-47. PubMed ID: 27177849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of current and lifetime substance use in schizophrenia.
    Fowler IL; Carr VJ; Carter NT; Lewin TJ
    Schizophr Bull; 1998; 24(3):443-55. PubMed ID: 9718636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Cougle JR; Hakes JK; Macatee RJ; Zvolensky MJ; Chavarria J
    J Clin Psychiatry; 2016 Apr; 77(4):e444-50. PubMed ID: 27137428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
    Johnson B; Richert T
    Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic.
    Weizman T; Gelkopf M; Melamed Y; Adelson M; Bleich A
    Aust N Z J Psychiatry; 2004; 38(1-2):42-6. PubMed ID: 14731193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features.
    Butelman ER; Chen CY; Fry RS; Kimani R; Levran O; Ott J; Correa da Rosa J; Kreek MJ
    Drug Alcohol Depend; 2018 Sep; 190():179-187. PubMed ID: 30041093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice-Identifying Group Differences and Predictors.
    Meyer M; Brunner P; Geissmann L; Gürtler M; Schwager F; Waldis R; Vogel M; Wiesbeck GA; Dürsteler KM
    Front Psychiatry; 2022; 13():846834. PubMed ID: 35392381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.